SARS-CoV-2-IN-11 is a potent and non-toxic inhibitor of SARS-CoV-2 3C-like protease (3CLpro), exhibiting IC50 and EC50 values of 0.17 nM and 1.45 nM, respectively; it shows potential as a SARS-CoV-2-specific antiviral agent by targeting the essential viral replication enzyme 3CLpro.